170
Participants
Start Date
September 25, 2023
Primary Completion Date
November 19, 2025
Study Completion Date
March 31, 2026
Multiparameter analysis of each sample
Retrospective and prospective samples will be collected and analyzed for the study of molecular and viral biomarkers. Simultaneously, fibroblastic tumor-associated cells (CAFs) will be isolated from prospective samples. Through co-cultivation with immortalized cell lines derived from anogenital and head-neck SCCs, these CAFs will enable the production of 3D organoids for use in experiments assessing the response to telomerase and deacetylase SIRT1 inhibitors, both in vitro and in preclinical models.
RECRUITING
Università del Piemonte orientale, Novara
RECRUITING
Azienda Ospedaliera Universitaria Pisana, Pisa
RECRUITING
Istituto Tumori IRCCS Giovanni Paolo II di Bari, Bari
RECRUITING
"Istituto Nazionale Tumori , Fondazione Pascale"
National Cancer Institute, Naples
OTHER